Suppr超能文献

相似文献

1
QIAreach QuantiFERON-TB for the diagnosis of infection.
Eur Respir J. 2022 Mar 24;59(3). doi: 10.1183/13993003.02563-2021. Print 2022 Mar.
2
First clinical evaluation of the QIAreach QuantiFERON-TB for tuberculosis infection and active pulmonary disease.
Pulmonology. 2022 Jan-Feb;28(1):6-12. doi: 10.1016/j.pulmoe.2021.07.003. Epub 2021 Aug 3.
4
Clinical application of QuantiFERON-TB Gold in-tube in the diagnosis and treatment of tuberculosis.
Eur J Clin Microbiol Infect Dis. 2020 Apr;39(4):607-612. doi: 10.1007/s10096-019-03768-9. Epub 2019 Nov 30.
8
Equal sensitivity of the new generation QuantiFERON-TB Gold plus in direct comparison with the previous test version QuantiFERON-TB Gold IT.
Clin Microbiol Infect. 2016 Aug;22(8):701-3. doi: 10.1016/j.cmi.2016.05.006. Epub 2016 May 13.
10
Comparing QuantiFERON-TB Gold Plus with Other Tests To Diagnose Mycobacterium tuberculosis Infection.
J Clin Microbiol. 2019 Oct 23;57(11). doi: 10.1128/JCM.00985-19. Print 2019 Nov.

引用本文的文献

3
Integrating pathogen- and host-derived blood biomarkers for enhanced tuberculosis diagnosis: a comprehensive review.
Front Immunol. 2024 Aug 9;15:1438989. doi: 10.3389/fimmu.2024.1438989. eCollection 2024.
6
Advances in TB testing.
Adv Clin Chem. 2023;115:33-62. doi: 10.1016/bs.acc.2023.03.003. Epub 2023 Mar 29.
7
Evolution of tuberculosis diagnostics: From molecular strategies to nanodiagnostics.
Tuberculosis (Edinb). 2023 May;140:102340. doi: 10.1016/j.tube.2023.102340. Epub 2023 Apr 5.
8
Challenges and the Way forward in Diagnosis and Treatment of Tuberculosis Infection.
Trop Med Infect Dis. 2023 Jan 28;8(2):89. doi: 10.3390/tropicalmed8020089.
9
First evaluation of the performance of portable IGRA, QIAreach® QuantiFERON®-TB in intermediate TB incidence setting.
PLoS One. 2023 Feb 10;18(2):e0279882. doi: 10.1371/journal.pone.0279882. eCollection 2023.
10
Clinical standards for the diagnosis, treatment and prevention of TB infection.
Int J Tuberc Lung Dis. 2022 Mar 1;26(3):190-205. doi: 10.5588/ijtld.21.0753.

本文引用的文献

1
Evaluation of a lateral-flow nanoparticle fluorescence assay for TB infection diagnosis.
Int J Tuberc Lung Dis. 2021 Nov 1;25(11):917-922. doi: 10.5588/ijtld.21.0391.
2
First clinical evaluation of the QIAreach QuantiFERON-TB for tuberculosis infection and active pulmonary disease.
Pulmonology. 2022 Jan-Feb;28(1):6-12. doi: 10.1016/j.pulmoe.2021.07.003. Epub 2021 Aug 3.
6
Ending tuberculosis by 2030-Pipe dream or reality?
Int J Infect Dis. 2020 Mar;92S:S51-S54. doi: 10.1016/j.ijid.2020.02.021. Epub 2020 Feb 27.
7
Treatment for latent tuberculosis infection in low- and middle-income countries: progress and challenges with implementation and scale-up.
Expert Rev Respir Med. 2020 Feb;14(2):195-208. doi: 10.1080/17476348.2020.1694907. Epub 2019 Nov 25.
8
QuantiFERON TB Gold Plus for the diagnosis of tuberculosis: a systematic review and meta-analysis.
J Infect. 2019 Nov;79(5):444-453. doi: 10.1016/j.jinf.2019.08.018. Epub 2019 Aug 29.
9
Analytical evaluation of QuantiFERON- Plus and QuantiFERON- Gold In-tube assays in subjects with or without tuberculosis.
Tuberculosis (Edinb). 2017 Sep;106:38-43. doi: 10.1016/j.tube.2017.06.002. Epub 2017 Jun 27.
10
Preliminary data on precision of QuantiFERON-TB Plus performance.
Eur Respir J. 2016 Sep;48(3):955-6. doi: 10.1183/13993003.01084-2016.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验